BDYS Stock Overview
BodyScan Corp. offers medical imaging services that include GE-Imatron Electron Beam Tomography (EBT) scanning for coronary artery disease (CAD), lung diseases, tumors, and stones detection.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
BodyScan Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.00001 |
52 Week High | US$0.003 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | -99.67% |
3 Month Change | n/a |
1 Year Change | -90.00% |
3 Year Change | -99.29% |
5 Year Change | -90.00% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
BDYS | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | 1.6% | 1.0% |
1Y | -90.0% | -1.4% | 21.9% |
Return vs Industry: BDYS underperformed the US Medical Equipment industry which returned -0.5% over the past year.
Return vs Market: BDYS underperformed the US Market which returned 24.9% over the past year.
Price Volatility
BDYS volatility | |
---|---|
BDYS Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BDYS's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine BDYS's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | n/a |
BodyScan Corp. offers medical imaging services that include GE-Imatron Electron Beam Tomography (EBT) scanning for coronary artery disease (CAD), lung diseases, tumors, and stones detection. The company is based in Irvine, California.
BodyScan Corp. Fundamentals Summary
BDYS fundamental statistics | |
---|---|
Market cap | US$8.19k |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs BDYS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BDYS income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did BDYS perform over the long term?
See historical performance and comparison